UNSPSC 51113001: Altretamine

This classification denotes an ethylenimine compound with the molecular formula C9H18N6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q8BIH59O7H, chemically known as 2,4,6-tris(dimethylamino)-s-triazine but more generally known as altretamine, which bears US NIH Compound Identifier 2123. European Medicines Agency schedules Altretamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05382MIG.

UNSPSC 51113001 Altretamine is a Commodity-tier code for procurement of the chemotherapy drug altretamine, used primarily in the treatment of ovarian cancer. State and local governments purchase altretamine through this code to stock hospital pharmacies, cancer treatment centers, and correctional-facility medical units. The procurements are typically issued by state departments of health, state prison systems, county hospital authorities, and municipal hospital networks seeking to source the drug for patient care or institutional formularies. Altretamine is purchased in bulk quantities—measured in vials, units, or courses of treatment—and specifications generally require FDA approval, chain-of-custody compliance, and adherence to state pharmaceutical procurement standards. Issuing bodies often use cooperative purchasing agreements or state pharmaceutical contracts to aggregate demand across multiple facilities and reduce per-unit costs.

The source provided contains no recent state or local contract opportunities tagged to UNSPSC 51113001. Without posted RFP, RFQ, IFB, or ITB notices in the most-recent-opportunities block, geographic distribution and issuing-body activity patterns cannot be characterized from current procurement signals. Firms pursuing altretamine supply contracts should monitor state health department procurement pages, state prison pharmacy solicitations, and county hospital purchasing offices in high-population states for future activity; altretamine typically appears in episodic, need-driven solicitations rather than standing blanket orders.